Why don't you grow up.Or go back to your sandbox. All that

New Post Public Reply Private Reply Replies (1) Message Board
fitzkarz I_told_you_so #7125
Why don't you grow up.Or go back to your sandbox.
All that you are is a whiny trouble maker.
Always trying to agitate and aggravate people.
All investor are adults and make there on decisions,to buy or to hold.
Everyone knows the risk.


The Risks of Penny Stocks


Risks of Penny StocksThe investing industry is one that is plagued with a history of deceit. Fortunately for the average investor, the Securities and Exchange Commission is there to protect us from these deceitful companies. Public companies that you can invest in are required to report important documents of information to the SEC so that this information is public and there is transparency in the market. Without this requirement, public companies could claim they have high revenues when they don’t, and anyone invested in that deceitful company would find their stock worth nothing when it became known that the company is just a shell, producing little to no revenue. If this sounds scary to you, then this is exactly what you’re getting when you invest in penny stocks!

Penny stocks exist on a different market exchange that is mostly unregulated by the Securities and Exchange Commission (Known as the OTCBB and Pink Sheets). The chances of finding a legitimate penny stock are very low. Most penny stocks are simply shell companies, that go through cycles of momentum and stock price because of the individuals who trade them. One day a penny stock can be up 300%, then the next day it can be down 90%, yet literally nothing at all has occurred in the company. Here are the reasons to stay away from the Penny Stocks:

Low Liquidity, High Risk
Unlike the stocks listed in major exchanges such as the S&P 500, penny stocks have very low daily volume. What this means is that you can buy shares of a penny stock, and in some cases have no one to sell it to! On average, penny stocks have volume equivalent to a few thousand dollars being exchanged every day. You want and sometimes need good liquidity in a stock so you can make a quick entry and exit, especially in penny stocks where the stock price can tank on a whim.

Pump and Dumpers
If you ever receive an email or possibly an advertisement that claims you need to immediately “invest” in a penny stock, you’ve been a target of pumping and dumping. The idea behind this is to create unfounded hype for a penny stock the pumper already owns, then as his victims buy into his hype and drive up the price of the stock significantly, the pumper sells his shares for a large profit. Meanwhile, those that bought into the hype will quickly lose their money as the upward stock momentum drops and the stock price heads south.

Inability to do Homework
Penny stocks differ from the stocks on major exchanges in that they have little to no following at all. You almost never find a penny stock being talked about by the financial media. There is usually no analyst opinions on penny stocks, which should put up an immediate red flag. If this company were actually worth something, wouldn’t analysts be interested in it?

Enjoy the Ride
Penny stocks are known for their wild and violent swings in momentum. You could walk away from your trading station/computer for an hour and come back and realize your penny stock went up 25%, then plummeted into the red. With penny stocks, you need to spend many hours every day watching your positions, otherwise you risk missing the golden opportunity of profit.

Unfortunately, I know this article probably won’t sway any new investors to avoid penny stocks. The lure of rapid, high percentage gains is too strong for naive investors. But hey, if you end up losing half your portfolio from a penny stock, don’t say I didn’t warn you.

Prospect Ventures, Inc. (IVAP) Stock Research Links

IVAP Board Company Profile Buy Rating Time & Sales News Filings Financials
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cepheid's FDA Clearance Boosts Hemorrhagic Fever Test

Updated Category News Views 81

Quick Detection for Deadly Viruses In the world of diagnostics, speed isn't just a luxury; it's a lifeline. Cepheid’s latest move—getting the FDA’s nod for their Xpert Hemorrhagic Fever Panel Test—is a big deal. Why? Imagine being able to detect nasty viruses like Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever in just over an hour. That's what this...

Continue Reading
Icahn Faces $225M Q3 Loss, But CVR Deal Shines

Updated Category News Views 30

Icahn Enterprises Stumbles in Q3, Losses Widen When a company's financial report starts with a loss, it's like stepping into a bar fight expecting cheers—you’re bound to get more than you bargained for. Icahn Enterprises L.P.'s third quarter report isn't exactly a rosy picture. We're staring down the barrel of a net loss of $225 million, a sharp contrast to the $287...

Continue Reading
MINISO Prepares to Reveal September 2026 Results

Updated Category News Views 74

News flash, folks — MINISO Group, that quirky IP-driven retailer we all have an eye on, has set the stage for its next big reveal. Come November 17, 2026, they’re gonna lay down their financial cards for the September quarter. It’s prime time for any investor keen on dissecting their performance and plans for the future. What the Call Means for Stakeholders MINISO's...

Continue Reading
Differentia Bio's AI: Transforming Drug Development Dynamics

Updated Category News Views 51

The Future of Drug Development: AI's New Role When it comes to pharmaceutical R&D, Some outfits are playing pin the tail on the donkey, but Differentia Bio over here is sharpening the pin with some futuristic gadgetry. Yep, they're jazzing up the game with AI-powered digital twins, building lifelike disease environments that predict therapeutic outcomes with precision...

Continue Reading
ISU and Ares Forge Path in Solid-State Battery Tech

Updated Category News Views 57

Solid-State Dreams Meet AI Magic Ah, the sweet sound of synergy. ISU Specialty Chemical and Ares Materials are brewing up something that could shake the battery world—solid-state cells juiced by AI-driven polymer magic. Now, the tech and finance geeks are likely on the edge of their seats. This isn't just another run-of-the-mill collab; it's a heavyweight match to speed...

Continue Reading
Doximity Faces Class Action: Investor Guidance Needed

Updated Category News Views 37

Doximity Lands in Hot Water: The Stakes for Investors Alright, traders, there's a storm brewing around Doximity (NYSE:DOCS), and it's a doozy. A class action lawsuit has been slapped on this digital platform for medical pros, and the accusations are serious. If you rode the wave and snagged yourself some shares between August 8, 2024, and May 13, 2026, you're right in the...

Continue Reading
RepData's New Platform Redefines Market Research Game

Updated Category News Views 34

Ever look at your market research and think, 'Is this really the best we can do?' RepData just rolled up like they own the place with their Verified Intelligence Platform (VIP), promising to make those wild data quality doubts a thing of the past. RepData’s Game-Changer in Research RepData's stepping into the ring with their VIP, aiming to shake up the way research...

Continue Reading
Oracle's $20 Billion Offering: What Investors Need to Know

Updated Category News Views 118

Oracle's Big Play: A $20 Billion Offering Nobody said playing in the big leagues was easy, and Oracle seems to be doubling down on that idea. Today, they spilled the beans on their ambition to rake in a cool $20 billion through an offering of common stock and senior notes. For those of us who keep a close eye on NYSE:ORCL, this is more than just a number—it's a signal...

Continue Reading
PRIMA Invests £10M to Propel CC Forum's Global Reach

Updated Category News Views 98

Strategic Commitment for Global Impact You've got to hand it to these folks—they're on a mission to roll up their sleeves and tackle climate change head-on. Max Studennikoff, the brains behind CC Forum, just inked a Letter of Intent with Alexander Zhardanovsky, founder of PRIMA, punctuated by an eye-popping £10 million pledge. It's all about boosting the Forum’s...

Continue Reading
Handle Plumbing Emergencies Swiftly, Expert Advises

Updated Category News Views 49

Fast Response Crucial in Plumbing Crises It's like nature's way of testing your mettle: a sudden plumbing emergency can make any homeowner feel like they're in over their head. The trick lies in how fast you act, and let me tell you, speed is everything in these situations. If you’ve never stared down a burst pipe or felt your heart drop at an overflowing toilet,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Growth and Trends in Nuclear Medicine

Updated Category News Views 326

Nuclear Medicine Market Trends and Growth Projections Nuclear medicine is becoming an essential part of modern healthcare systems, offering significant diagnostic and therapeutic benefits. Recent industry analysis shows that the nuclear medicine market, valued at US$ 5.2 billion in 2022, is projected to grow to an astounding US$ 11.4 billion by 2031. This growth...

Continue Reading
Bitcoin Resilience: Experts Forecast Continued Growth Amid Dip

Updated Category News Views 107

Experts Forecast Bitcoin's Continued Growth In recent discussions, cryptocurrency experts have expressed a common belief that Bitcoin's long-term trajectory remains robust despite current fluctuations. Bitcoin has faced challenges in the short term, but the overarching consensus suggests that its bull market is far from over. The Impact of Federal Reserve Policies...

Continue Reading
Iovance Investors Urged to Act Before the July 14 Deadline

Updated Category News Views 170

Important Notice for Iovance Investors Levi & Korsinsky, LLP is reaching out to investors of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) regarding a class action securities lawsuit. This notice serves to inform shareholders of the impending deadline for becoming a lead plaintiff, which is set for July 14, 2025. Class Action Overview The legal action aims to recover...

Continue Reading
Startek® South Africa Achieves Best Employer Brand Award

Updated Category News Views 256

Startek® South Africa Celebrates Employer Branding Success Startek®, a leader in global customer experience solutions, is making waves in the industry with its recent accolade at the South Africa Leadership Awards. Startek's South Africa operations received the prestigious Best Employer Brand Award for 2025, recognizing their exceptional approach to employee engagement...

Continue Reading
ESS Tech Launches Energy Center™ Product for Sustainable Energy

Updated Category News Views 220

ESS Tech Introduces Energy Center™ Product ESS Tech, Inc. (NYSE: GWH), a frontrunner in the field of long-duration energy storage systems, has proudly announced the commercial launch of its innovative Energy Center™ product. This milestone comes with the successful delivery of multiple systems to a prominent utility in Florida, along with the completion of...

Continue Reading